Capstone Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $2.97M | Sell |
138,470
-13,700
| -9% | -$294K | 0.08% | 284 |
|
|
2017
Q1 | $2.61M | Buy |
152,170
+8,340
| +6% | +$143K | 0.07% | 324 |
|
|
2016
Q4 | $2.58M | Buy |
143,830
+2,820
| +2% | +$50.6K | 0.07% | 316 |
|
|
2016
Q3 | $2.93M | Buy |
141,010
+1,000
| +0.7% | +$20.8K | 0.08% | 286 |
|
|
2016
Q2 | $3.77M | Buy |
140,010
+3,294
| +2% | +$88.6K | 0.11% | 209 |
|
|
2016
Q1 | $3.7M | Sell |
136,716
-1,450
| -1% | -$39.3K | 0.11% | 245 |
|
|
2015
Q4 | $4.01M | Buy |
138,166
+7,570
| +6% | +$220K | 0.12% | 218 |
|
|
2015
Q3 | $3.54M | Sell |
130,596
-5,364
| -4% | -$145K | 0.11% | 229 |
|
|
2015
Q2 | $3.72M | Sell |
135,960
-4,380
| -3% | -$120K | 0.11% | 241 |
|
|
2015
Q1 | $3.75M | Buy |
140,340
+21,552
| +18% | +$575K | 0.11% | 241 |
|
|
2014
Q4 | $2.51M | Buy |
118,788
+18,128
| +18% | +$384K | 0.07% | 312 |
|
|
2014
Q3 | $2.4M | Sell |
100,660
-2,160
| -2% | -$51.4K | 0.08% | 285 |
|
|
2014
Q2 | $2.38M | Sell |
102,820
-370
| -0.4% | -$8.55K | 0.08% | 301 |
|
|
2014
Q1 | $2.36M | Sell |
103,190
-395,660
| -79% | -$9.03M | 0.07% | 321 |
|
|
2013
Q4 | $1.84M | Buy |
498,850
+407,100
| +444% | +$1.5M | 0.05% | 398 |
|
|
2013
Q3 | $1.55M | Buy |
91,750
+7,370
| +9% | +$125K | 0.04% | 553 |
|
|
2013
Q2 | $1.31M | Buy |
+84,380
| New | +$1.31M | 0.03% | 590 |
|